Raise awareness of environmental health issues in order to better protect our children and future generations.

EMF Studies

30 January 2013

Research Centers and Units Associated with the European Research Institute on Cancer and the Environment (ECERI)

The European Research Institute on Cancer and the Environment (ECERI), located in Brussels, is a research organization federating scientific international units and research centers that have decided to devote part of their research activities to the environment as a cause of diseases, and that have agreed to share their expertise and skills. The objective of the ECERI network--designed to be of a very high scientific level, and therefore supported by several American scientists and Nobel Prize winners--is to obtain significant funding from national and European Union authorities, for research on specific programs in this neglected area that is of common interest to the network. 

If you want your unit or research center to be part of the ECERI Network, please fill in and send us the following questionnaire at this address : sg.eceri@gmail.com 
Questionnaire to research units and centers

List of research centers and units associated to ECERI :

Alessandra Lisi International Centre on Birth Defects and Prematurity, Roma (Italy) : Pierpaolo Mastroiacovo 

Dr Pierpaolo Mastroiacovo is Professor of Pediatrics, and formerly Chair of the Department of Pediatrics at the Catholic University of Rome. At present he is Director of the Alessandra Lisi International Centre on Birth Defects and Prematurity and Director of the Centre of the ICBDSR. His main research field is the epidemiology of birth defects, and his current main interest is to promote preconception health in Italy.

Brain Research Institute, University of Zurich (Switzerland) : Isabelle Mansuy 

Isabelle Mansuy is member of the Swiss Academy of Medical Science, the Research Council of the Swiss National Foundation, of the Research Council of the Fyssen Foundation and of EMBO, and was recently elected Chevalier dans l'Ordre National du Mérite in France. She is acting in multiple review boards including the European Neuroscience Institute Göttingen, the German Federal Ministry of Education and Research, CNRS, etc. She is chief co-editor of BioMolecular Concepts, and member of the editorial board of Hippocampus, Neurobiology of Diseases, Frontiers in Behavioral Neurosciences, Biology of Mood and Anxiety Disorders, and Frontiers in Epigenomics. She co-authored several reviews and books in the field of molecular cognition and neuroepigenetics. 

Isabelle Mansuy is Professor in Molecular Cognition at the Medical Faculty of the University Zürich, and the Department of Biology of the Swiss Federal Institute of Technology Zürich (ETHZ). She is part of the Center for Neuroscience Zürich. She completed a PhD in Developmental Neurobiology at the Friedrich Miescher Institute in Basel, Switzerland and the Université Louis Pasteur Strasbourg, France, then a postdoctoral training in the lab of Eric Kandel at the Center for Learning and Memory at Columbia University in New York. She was appointed Assistant Professor in Neurobiology at the ETHZ in Dec 1998. Her research examines the epigenetic basis of complex brain functions and focuses in particular, on cognitive functions and behavior in mammals. Her work revealed the existence of molecular suppressors of learning and memory in the adult mouse brain, and identified the Ser/Thr protein phosphatases calcineurin and PP1 as such suppressors. It demonstrated their importance in cognitive defects associated with aging, Alzheimer’s disease and neurodegeneration. It also revealed their role in chromatin remodeling in the adult brain, and in the epigenetic control of memory formation and synaptic plasticity. 

Isabelle Mansuy’s research also examines the mechanisms underlying the influence of detrimental environmental factors on behavior across generations. This work recently demonstrated that early stress in mice induces depression and impulsivity, and impairs social skills and cognitive functions, and that these behavioral symptoms are transmitted across several generations. It showed that epigenetic mechanisms involving DNA methylation are associated with the inheritance of the behavioral defects. This research is pluridisciplinary and combines genetically and environmentally modified animal models, epigenetic methods, molecular, behavioral, electrophysiological, proteomic and imaging techniques.

Centre Méditerranéen de Médecine Moléculaire (C3M), Nice : Mohammed Benhamed (INSERM), Patrick Fenichel (CHU et INSERM) 
Professor Patrick FENICHEL is Head of the Department of Endocrinology and Reproductive Medicine at the University Hospital (CHU) of Nice, France. He is in charge of the team 5 (Environment Reproduction and Hormone Dependent Cancer) of INSERM U895 unit, Research Institute C3M (Centre Méditerranéen de Médecine Moléculaire).

Department of Biology, Metastasis Research Laboratory, University of Liège (Belgium) : Vincent Castronovo,
Metastasis Research Laboratory (MRL) was founded in 1992 by Professor Vincent Castronovo. Its main aim is the study of the molecular mechanisms involved in tumor growth and metastasis dissemination. The laboratory is linked to the Medicine Faculty of the University of Liege. It is active in the field of cancer biology within GIGA-cancer. MRL is composed by about twenty people including an academic and three permanent scientists. The main research topics are : the involvement of SIBLINGs (small integrin-binding ligand, N-linked glycoprotein) in cancer biology - read more, the description of the role plays by HDACs (histonedeacetylase) in angiogenesis, DNA repair and telomer maintenance, the detection of tumour specific biomarkers in the frame of a therapeutic targeting, the involvement of cyclooxygenase-2 (COX-2) in pancreatic tumor growth.

Department of Human and Environmental Sciences, Faculty of Medicine, University of Pisa (Italy) :Lucia Migliore 
Area of Interest: presently interested in the study of genetic and environmental factors involved in the onset of complex neurodegenerative diseases (Alzheimer disease, Parkinson disease, Amiotrophic Lateral Sclerosis), according to the following research lines: Neurotoxins that may play a role in neurodegenerative disorders: we are focussing our attention on some neurotoxic metals, able to induce oxidative damage, Identification of “a battery of assays” for the detection of oxidative damage at peripheral level in of subjects at risk to develop AD, or with pre-pathogenic conditions (i.e. Mild Cognitive Impairment subjects, Down syndrome patients, young mothers of DS children), Studies aimed to primary prevention in subjects with pre-pathogenic conditions of neurodegenerative diseases, Studies on susceptibility genes (i.e. folate gene polymorphisms), Reduction of toxicity of conjugated nanoparticles for drug delivery.

Department of Neuroscience, Karolinska Institute (Sweden) : Olle Johansson

The group investigates health effects of modern, man-made electromagnetic fields as well as the functional impairment electrohypersensitivity. It introduced the clinical term "screen dermatitis" to explain the cutaneous damages that developed in the late 1970's when office workers, first mostly women, began to be placed in front of computer monitors. It called for action along lines of occupational medicine, biophysics and biochemistry, as well as neuroscience and experimental dermatology. The working hypothesis early became that persons with the impairment electrohypersensitivity react in a cellularly correct way to the electromagnetic radiation, maybe in concert with chemical emissions such as plastic components, flame retardants, etc., in a highly specific way and with a completely correct avoidance reaction -- just as you would do if you had been exposed to e.g. sun rays, X-rays, radioactivity or chemical odours. Nowadays, electrohypersensitivity (EHS) is in Sweden an officially fully recognized functional impairment (i.e., it is not regarded as a disease). The team has, in addition, worked in great depth in areas such as skin diseases, cancer, child delivery, female urine incontinence, oral mucosa diseases, brain and spinal cord morphology, synaptology and chemical transmission, peripheral nervous system-related issues, cardiac function, skeletal muscle function and disease, and connective tissue ripening phenomena.

Department of Oncology, Orebro Medical Center (Sweden) : Lennart Hardell

Dr Lennart Hardell is professor in oncology and cancer epidemiology at the UniversityHospital in Orebro, Sweden. Most of his research has been on risk factors for cancer such as exposure to pesticides and persistent organic pollutants. Examples of such agents are herbicides, dioxins, PCBs and brominated flame-retardants. During recent years he and his co-workers have studied use of cellular and cordless telephones and the risk for brain tumours. He works also as a consultant at the Department of Oncology at the hospital.

Environmental Epidemiology and Cancer Registry Unit, National Cancer Institute, Milano (Italy):Paolo Crosignani
Epidemiology for Cancer Prevention, Inserm and University of Bordeaux (France) : Annie Sasco

European Centre for Environment and Human Health, University of Exeter (UK) : Lora Fleming

Gastrointestinal Surgery Service, Hospital Clinic of Barcelona and AT Consultants (Spain) : SalvadoraDelgado and Manuel Almarcha 

GreenTox/University of Zürich (Switzerland) : Margret Schlumpf

Metalund, Lund University (Sweden) : Maria Albin

Associated Units (international collaborations) :

Boston University School of Public Health (United States) : Richard Clapp


No comments:

Post a Comment